Quick Comparison

Omega-3 (DHA)Reishi
Half-Life20-67 hours (plasma), but brain DHA turns over slowly over weeksBioactive compounds accumulate with daily use
Typical DosageStandard: 1-2 g combined EPA/DHA daily (aim for at least 500 mg DHA). For depression: 1-2 g EPA-dominant fish oil. Triglyceride form is better absorbed than ethyl ester. Take with a fatty meal.Standard: 1000-3000 mg daily of extract. Dual-extract (water + alcohol extraction) preferred to capture both polysaccharides and triterpenes. Take in the evening due to calming effects. Spore oil: 500-1000 mg daily. Effects build over 2-4 weeks.
AdministrationOral (softgels, liquid). Triglyceride or phospholipid forms preferred over ethyl ester for bioavailability. Take with food containing fat.Oral (capsules, powder, tincture, tea). Dual-extract preferred. Bitter taste in powder/tea form.
Research Papers10 papers8 papers
Categories

Mechanism of Action

Omega-3 (DHA)

DHA is a structural component of neuronal phospholipids (particularly phosphatidylethanolamine and phosphatidylserine in synaptic membranes), maintaining membrane fluidity which is essential for G-protein-coupled receptor function, ion channel gating, and synaptic vesicle fusion. DHA is metabolized by 15-lipoxygenase to specialized pro-resolving mediators (SPMs) including neuroprotectin D1 (NPD1), which actively resolve neuroinflammation by reducing NF-kappaB activation and pro-inflammatory cytokine production. DHA supports BDNF expression through modulation of the CREB pathway and promotes synaptic plasticity by enhancing long-term potentiation (LTP) and dendritic spine density. It also influences neurotransmitter receptor conformation and binding efficiency. Deficiency impairs membrane signaling, increases neuroinflammation, and accelerates cognitive decline.

Reishi

Reishi's triterpenes (ganoderic acids A, C, D, H; ganoderenic acids) modulate the HPA axis by reducing CRH and ACTH release, lowering cortisol via glucocorticoid receptor feedback. Ganoderic acids have direct sedative effects through GABA-A receptor modulation (possibly allosteric at the benzodiazepine site) and 5-HT2A/2C serotonergic modulation. Beta-(1,3)-(1,6)-glucan polysaccharides bind Dectin-1 and complement receptor 3 (CR3) on macrophages, natural killer cells, and dendritic cells, activating NF-kB and MAPK signaling for immune modulation. Reishi inhibits histamine release from mast cells via Fc epsilon RI downregulation and stabilizes mast cell membranes (anti-allergic effect). Antioxidant properties involve upregulation of superoxide dismutase (SOD1/SOD2), catalase, and glutathione peroxidase. Ganoderic acids may also inhibit 5-alpha-reductase and ACE.

Risks & Safety

Omega-3 (DHA)

Common

Fishy aftertaste, burping, mild gastrointestinal discomfort.

Serious

High doses (>3 g/day) may increase bleeding risk — caution with blood thinners. Fish oil quality matters — choose products tested for mercury and oxidation.

Rare

Allergic reaction in people with fish/shellfish allergy.

Reishi

Common

Digestive discomfort, dry mouth, dizziness.

Serious

Rare hepatotoxicity reported — avoid with liver disease. May interact with blood thinners and immunosuppressants.

Rare

Allergic reaction, nosebleeds.

Full Profiles